title: Effect of L-arginine on lower oesophageal sphincter motility in man.
abstract: OBJECTIVE
  Inhibitory responses of the lower oesophageal sphincter (LOS) are mediated via an L-arginine/nitric oxide (NO) pathway. L-arginine is known as the precursor of NO. We have studied the effect of intravenous L-arginine on LOS motility in man.
  
  
  METHODS
  Twelve healthy subjects participated in a double-blind, placebo-controlled randomized study.
  
  
  METHODS
  We investigated the effect of continuous infusion of L-arginine (500 mg/kg body weight/120 min) in six subjects under fasting conditions. Six other subjects were studied under postprandial conditions. LOS pressure (LOSP), swallow-induced LOS relaxations and transient lower oesophageal sphincter relaxations (TLOSR) were measured with sleeve manometry combined with pH metry. The meal consisted of a carbohydrate-high fat meal. Blood samples were taken before and after administration of L-arginine or saline to determine plasma levels of amino acids, cholecystokinin and gastrin.
  
  
  RESULTS
  Plasma levels of arginine and citrulline significantly (P < 0.05) increased during L-arginine infusion. L-arginine did not affect plasma hormone levels. Under fasting conditions, LOSP and TLOSR were not influenced by L-arginine. Ingestion of the carbohydrate-high fat meal significantly decreased LOSP. L-arginine did not significantly influence TLOSR frequency, either under fasting conditions or postprandially.
  
  
  CONCLUSIONS
  These results suggest that in humans under fasting or postprandial conditions intravenous infusion of L-arginine does not influence LOS motility.
authors.affiliation: Department of Gastroenterology-Hepatology, Leiden University Medical Center, The Netherlands.
authors.forename: J W
authors.initials: JW
authors.lastname: Straathof
authors.forename: M
authors.initials: M
authors.lastname: Adamse
authors.forename: W
authors.initials: W
authors.lastname: Onkenhout
authors.forename: C B
authors.initials: CB
authors.lastname: Lamers
authors.forename: A A
authors.initials: AA
authors.lastname: Masclee
mesh_terms: D000328:Adult; D001120:Arginine / Q000008:administration & dosage / Q000494:pharmacology*; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004311:Double-Blind Method; D004943:Esophagogastric Junction / Q000187:drug effects* / Q000502:physiology; D005215:Fasting; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007262:Infusions, Intravenous; D008297:Male; D008365:Manometry
chemical_list: D004040:Dietary Carbohydrates; D004041:Dietary Fats; D001120:Arginine